Active Pharmaceutical Ingredient

Rentiapril — CAS 79778-41-9

Also known as: SA 446; Rentiapril HCl

GMP Certified IP / BP / EP / USP ACE Inhibitor / Antihypertensive Aurangabad, India
Rentiapril API Supplier Manufacturer Aurangabad Maharashtra India — Mediocon Inc
Rentiapril IP / BP / EP / USP  |  GMP Certified  |  Mediocon Inc, Maharashtra, India
CAS No: 79778-41-9

Product Overview

Rentiapril is a high-purity Active Pharmaceutical Ingredient (API) classified under ACE Inhibitor / Antihypertensive. Mediocon Inc manufactures GMP-compliant Rentiapril at its state-of-the-art facility in Aurangabad, Maharashtra, India, supplying pharmaceutical companies worldwide with consistent quality and full regulatory documentation.

Therapeutic Applications
  • Hypertension treatment via ACE inhibition
  • Heart failure management
  • Renal protection in hypertensive patients
  • Cardiovascular research applications

Technical Specifications

ParameterSpecification
CAS Number79778-41-9
Molecular FormulaC₁₄H₁₇NO₄S
Molecular Weight295.36 g/mol
GradeIP / BP / EP / USP
CategoryACE Inhibitor / Antihypertensive
AssayNLT 98.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Batch NoREN/24032026
Mfg DateMAR 2026
Exp DateFEB 2031
Packing25 kg HDPE drums / as per requirement

Quality & Compliance

  • GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
  • Full pharmacopoeial compliance: IP / BP / EP / USP standards
  • Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
  • Stringent in-process quality control at every manufacturing stage
  • HPLC purity testing and spectroscopic identification (IR, NMR)
  • Cold-chain and controlled-environment storage facilities available
  • Exported to 40+ countries with full regulatory support
💬
Mediocon AI
Hello 👋 How can I help you today?